SCHEMBL65257

SCHEMBL65257

C1=NCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20411704 1.00
SCHEMBL20411652 1.00
SCHEMBL20411638 1.00
SCHEMBL20411669 1.00
SCHEMBL20411674 1.00
SCHEMBL688668 0.96
SCHEMBL3077469 0.96
SCHEMBL11098919 0.96
SCHEMBL22063796 0.96
SCHEMBL11183047 0.96

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 23217 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122094940-A Ionizable lipids and uses thereof 2026-05-26 CN claimed
US-20260137700-A1 PHARMACEUTICAL COMBINATION OF PRMT5 INHIBITOR AND DNA DAMAGE-INDUCING SUBSTANCE SK BIOPHARMACEUTICALS CO LTD (KR) 2026-05-21 US claimed
EP-3768675-B1 NOVEL TRIAZOLONE DERIVATIVES OR SALTS THEREOF AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME YUHAN CORP (KR) 2026-04-01 EP claimed
US-20250347994-A1 RESIST COMPOSITION AND PATTERN FORMATION METHOD USING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2025-11-13 US claimed
WO-2025226846-A1 CDK12 INHIBITORS WITH IMIDAZOLE[1,2-A] PYRAZINES H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (US) 2025-10-30 WO claimed
US-12441754-B2 Galactoside inhibitor of galectins GALECTO BIOTECH AB (DK) 2025-10-14 US claimed
US-12435068-B2 Anthelmintic compounds ELANCO ANIMAL HEALTH GMBH (DE) 2025-10-07 US claimed
US-20250291247-A1 AMINE COMPOUND, RESIST COMPOSITION INCLUDING THE SAME, AND METHOD OF FORMING PATTERN BY USING THE RESIST COMPOSITION SAMSUNG ELECTRONICS CO., LTD. (KR) 2025-09-18 US claimed
US-12415803-B2 Fused imidazopyridines as reversible inhibitors of Brutons Tyrosine Kinase (BTK) MERCK PATENT GMBH (DE) 2025-09-16 US claimed
US-12391682-B2 Isoquinoline derivatives and their use for the treatment of parasitic infections ELANCO ANIMAL HEALTH GMBH (DE) 2025-08-19 US claimed
US-4118566-A Δ2,3 -1,4-Morpholine-2-carboxylic acid derivatives as antibacterial agents BRISTOL-MYERS COMPANY (US) 1978-10-03 US claimed
US-4113946-A Δ2,3 -1,4-Morpholine-2-carboxylic acid derivatives as antibacterial agents BRISTOL-MYERS COMPANY (US) 1978-09-12 US claimed
US-4112230-A Δ2,3 -1,4 Morpholine-2-carboxylic acid derivatives as antibacterial agents BRISTOL-MYERS COMPANY (US) 1978-09-05 US claimed
US-4088653-A FROM A CARBONYLHYDRAZIDE AND AN ARYL-PYRIDINIUM HALIDE, REDUCTION WITH A BOROHYDRIDE; ANALGESICS, ANTIINFLAMMATORY AND HYPERGLYCEMIC AGENTS CANADIAN PATENTS AND DEVELOPMENTS LIMITED (CA) 1978-05-09 US claimed
US-4081450-A 1,3,4-Trisubstituted-4-arylpiperidines and their preparation ELI LILLY AND COMPANY (US) 1978-03-28 US claimed
US-4051117-A Triazole-azo-phenyl cationic dyestuffs BAYER AKTIENGESELLSCHAFT (DT) 1977-09-27 US claimed
US-4021551-A INDUCERS FOR INTERFERON FORMATION BOEHRINGER INGELHEIM GMBH (DT) 1977-05-03 US claimed
US-4006127-A Cationic diazacyanine dyestuffs BAYER AKTIENGESELLSCHAFT (DT) 1977-02-01 US claimed
US-3933830-A FROM 4-(2-PYRIDYLAMIDOETHYL) PYRIDINES REDUCED WITH HYDROGEN AND A NOBLE METAL CATALYST PFIZER INC. (US) 1976-01-20 US claimed
US-3931155-A ANTICOAGULANT RICHARDSON-MERRELL INC. (US) 1976-01-06 US claimed